July 7, 2026
With physician medical groups accounting for a record 46% of healthcare M&A volume in early 2026, the market for practice acquisitions has reached a gold standard of competition. However, both buyers and sellers can underestimate the “soft costs” and legal friction points that erode certainty before closing.
The Strategic Reality: For a typical medical practice acquisition, transaction costs: including legal, accounting, and valuation fees: now average between 3% and 7% of the total enterprise value. On a $10 million deal, this represents a $300,000 to $700,000 cash requirement before the first patient is seen under new ownership, while sellers also face pressure around reps, warranties, indemnification, and post-close liability.
The Professional Standard for Due Diligence 🏥
In the current regulatory climate, CMS reimbursement volatility has pushed the necessity for deeper diligence. Buyers must budget for:
✅ Legal Fees: Navigating Stark Law and Anti-Kickback compliance ($75k–$300k).
✅ Quality of Earnings (QoE): Scrutinizing payer mix and denial rates ($50k–$200k).
✅ FMV Opinions: Ensuring purchase price alignment with federal standards ($25k–$75k).
Sellers also need to prepare for the same scrutiny from the other side of the table. A seller-focused review should anticipate document requests, compensation questions, contract assignment issues, and the likelihood that the buyer will test every assumption tied to future cash flow.
Step 7: Finalize Legal and Contractual Details for Buyers and Sellers 🩺
This is where deals often get tense. Sellers commonly prefer to use their own counsel and push for tighter indemnification caps because they want finality after closing, not open-ended exposure that follows them for years. That position is rational, but buyers still need disciplined protections around known risks, billing practices, and compliance representations.
From a practical standpoint:
✅ For sellers: confirm the purchase price is supported by current fair market value guidance and that compensation arrangements can withstand review.
✅ For buyers: verify FMV opinions, confirm Stark Law compliance, and review employment, lease, payer, and vendor contracts before accepting indemnification limitations.
✅ For both parties: align legal language with operational reality so post-close disputes do not undermine the transaction.
Failing to account for these “white-glove” advisory services can lead to significant capital optimization issues post-closing.
Strategic Use of AR-Backed Working Capital to Offset Acquisition Fees 🩺
To maintain a strategic advantage, savvy buyers and sellers are increasingly utilizing AR-Backed Working Capital to preserve cash reserves during closing. Rather than draining the practice’s operating account to pay for legal bills, working capital true-ups, or advisory fees, White Coat Financial Partners provides financing against the aggregate sum of your Accounts Receivable.
This non-notification model ensures you remain in full control of billing while accessing the liquidity needed for a smooth transition. That can be especially valuable when legal negotiations stretch out around indemnification caps, compliance diligence, or closing deliverables. Our scalable solutions provide the certainty required to close complex deals without relying solely on personal credit constraints.
Unlock your practice’s potential today.
Contact White Coat Financial Partners to secure your transition capital.
🌐 thewhitecoatadvantage.com
📞 910-688-5077
Author: Stuart D. Anderson | President, White Coat Financial Partners.
About the Author
Stuart D. Anderson is the founder and President of White Coat Financial Partners, a Fayetteville, NC-based firm providing specialized financial and advisory services for healthcare professionals and organizations. With deep expertise in AR-backed working capital, M&A brokerage, and Lean Six Sigma process optimization, Stuart helps medical practices unlock capital, streamline operations, and achieve long-term financial stability. Connect with Stuart on LinkedIn.